View in EDS HTML Full Text PDF Full Text

Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development

Saved in:
Bibliographic Details
Title: Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development
Language: English
Authors: DiGuiseppi, Carolyn (ORCID 0000-0002-6440-7817), Crume, Tessa, Van Dyke, Julia, Sabourin, Katherine R., Soke, Gnakub N., Croen, Lisa A., Daniels, Julie L., Lee, Li-Ching, Schieve, Laura A., Windham, Gayle C., Friedman, Sandra, Robinson Rosenberg, Cordelia
Source: Journal of Autism and Developmental Disorders. Nov 2022 52(11):5064-5071.
Availability: Springer. Available from: Springer Nature. One New York Plaza, Suite 4600, New York, NY 10004. Tel: 800-777-4643; Tel: 212-460-1500; Fax: 212-460-1700; e-mail: customerservice@springernature.com; Web site: https://link.springer.com/
Peer Reviewed: Y
Page Count: 8
Publication Date: 2022
Sponsoring Agency: Centers for Disease Control and Prevention (CDC) (DHHS/PHS)
Contract Number: U10DD000180
U10DD000181
U10DD000182
U10DD000183
U10DD000184
U10DD000498
Document Type: Journal Articles
Reports - Research
Descriptors: Pregnancy, Prenatal Influences, Marijuana, Drug Use, Mothers, Autism Spectrum Disorders, Children, Child Development, Developmental Delays, Probability, Risk, Models, Cohort Analysis, Epidemiology
DOI: 10.1007/s10803-021-05339-4
ISSN: 0162-3257
1573-3432
Abstract: The association of autism spectrum disorder (ASD) with self-reported maternal cannabis use from 3 months pre-conception to delivery ("peri-pregnancy") was assessed in children aged 30-68 months, born 2003 to 2011. Children with ASD (N = 1428) were compared to children with other developmental delays/disorders (DD, N = 1198) and population controls (POP, N = 1628). Peri-pregnancy cannabis use was reported for 5.2% of ASD, 3.2% of DD and 4.4% of POP children. Adjusted odds of peri-pregnancy cannabis use did not differ significantly between ASD cases and DD or POP controls. Results were similar for any use during pregnancy. However, given potential risks suggested by underlying neurobiology and animal models, further studies in more recent cohorts, in which cannabis use and perception may have changed, are needed.
Abstractor: As Provided
Entry Date: 2022
Accession Number: EJ1351479
Database: ERIC
Full text is not displayed to guests.
Description
Abstract:The association of autism spectrum disorder (ASD) with self-reported maternal cannabis use from 3 months pre-conception to delivery ("peri-pregnancy") was assessed in children aged 30-68 months, born 2003 to 2011. Children with ASD (N = 1428) were compared to children with other developmental delays/disorders (DD, N = 1198) and population controls (POP, N = 1628). Peri-pregnancy cannabis use was reported for 5.2% of ASD, 3.2% of DD and 4.4% of POP children. Adjusted odds of peri-pregnancy cannabis use did not differ significantly between ASD cases and DD or POP controls. Results were similar for any use during pregnancy. However, given potential risks suggested by underlying neurobiology and animal models, further studies in more recent cohorts, in which cannabis use and perception may have changed, are needed.
ISSN:0162-3257
1573-3432
DOI:10.1007/s10803-021-05339-4